Biomaneo
Dijon, France
Biomaneo designs and markets innovative medical analysis kits using mass spectrometry for detailed protein analysis. Their solutions target neonatal screening and pathology diagnosis within hospital laboratories. Operating on a B2B model, they serve healthcare professionals and corporate entities. Key offerings include NeoSickle for sickle cell disease and NeoHemog for hemoglobin variants. The company integrates bioinformatics to process data and assist in interpretation, aiming to automate biological screening, enhance efficiency, reduce mortality, and lower analysis costs. With CE IVDR and ISO 13485 certifications, Biomaneo bridges bioconcepts with clinical applications through precise and traceable diagnostic tools.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2016
- Website
- biomaneo.fr/
Only accessible to MedStartr community members.
Join nowWhat do you think of Biomaneo?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now